Expression of the stem cell marker nestin in pre/hypertrophic chondrocytes in osteochondroma

Journal of International Medical Research

Volumn 39, Issue 2, 2011, Pages 348-357

  Du, K ^a   Peng, Y ^a   Zhang, L ^a   Liang, A ^a   Huang, D ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

Growth plate; Immunohistochemistry; Nestin; Osteochondroma

Indexed keywords

NESTIN;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BONE PLATE; CARTILAGE CELL; CELL ENLARGEMENT; CHILD; CLINICAL ARTICLE; CLINICAL EVALUATION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; OSTEOCHONDROMA; PRESCHOOL CHILD; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN RESTRICTION; SCHOOL CHILD;

EID: 79955652914     PISSN: 03000605     EISSN: None     Source Type: Journal    
DOI: 10.1177/147323001103900202     Document Type: Article

References (38)

1. Lendahl U, Zimmerman LB, McKay RD: CNS stem cells express a new class of intermediate filament protein. Cell 1990; 60: 585-595.
2. Tohyama T, Lee VM, Rorke LB, et al: Nestin expression in embryonic human neuroepithelium and in human neuroepithelial tumor cells. Lab Invest 1992; 66: 303-313.
3. Dahlstrand J, Zimmerman LB, McKay RD, et al: Characterization of the human nestin gene reveals a close evolutionary relationship to neurofilaments. J Cell Sci 1992; 103: 589-597.
4. Michalczyk K, Ziman M: Nestin structure and predicted function in cellular cytoskeletal organisation. Histol Histopathol 2005; 20: 665-671.
5. Mokrý J, Cízková D, Filip S, et al: Nestin expression by newly formed human blood vessels. Stem Cells Dev 2004; 13: 658-664.
6. Wiese C, Rolletschek A, Kania G, et al: Nestin expression-a property of multi-lineage progenitor cells? Cell Mol Life Sci 2004; 61: 2510-2522.
7. Vaittinen S, Lukka R, Sahlgren C, et al: The expression of intermediate filament protein nestin as related to vimentin and desmin in regenerating skeletal muscle. J Neuropathol Exp Neurol 2001; 60: 588-597.
8. Frisén J, Johansson CB, Török C, et al: Rapid, widespread, and longlasting induction of nestin contributes to the generation of glial scar tissue after CNS injury. J Cell Biol 1995; 131: 453-464.
9. Kawamoto M, Ishiwata T, Cho K, et al: Nestin expression correlates with nerve and retroperitoneal tissue invasion in pancreatic cancer. Hum Pathol 2009; 40: 189-198.
10. Yamada H, Takano T, Ito Y, et al: Expression of nestin mRNA is a differentiation marker in thyroid tumors. Cancer Lett 2009; 280: 61-64.
11. Yang XH, Wu QL, Yu XB, et al: Nestin expression in different tumours and its relevance to malignant grade. J Clin Pathol 2008; 61: 467-473.
12. Veselska R, Hermanova M, Loja T, et al: Nestin expression in osteosarcomas and derivation of nestin/CD133 positive osteosarcoma cell lines. BMC Cancer 2008; 8: 300.
13. Parry S, Savage K, Marchio C, et al: Nestin is expressed in basal-like and triple negative breast cancers. J Clin Pathol 2008; 61: 1045-1050.
14. Ehrmann J, Kolár Z, Mokry J: Nestin as a diagnostic and prognostic marker: immunohistochemical analysis of its expression in different tumours. J Clin Pathol 2005; 58: 222-223.
15. Toti P, Regoli M, Nesi G, et al: Nestin expression in normal adrenal gland and adrenocortical tumors. Histol Histopathol 2005; 20: 1115-1120.
16. Lobo MV, Arenas MI, Alonso FJ, et al: Nestin, a neuroectodermal stem cell marker molecule, is expressed in Leydig cells of the human testis and in some specific cell types from human testicular tumours. Cell Tissue Res 2004; 316: 369-376.
17. Kitsoulis P, Galani V, Stefanaki K, et al: Osteochondromas: review of the clinical, radiological and pathological features. In Vivo 2008; 22: 633-646.
18. Khurana J, Abdul-Karim F, Bovée JVMG: Osteochondroma. In: World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Soft Tissue and Bone (Fletcher CDM, Unni KK, Mertens F, eds). Lyon: IARC, 2002; pp 234-236.
19. Bovée JV, Cleton-Jansen AM, Taminiau AH, et al: Emerging pathways in the development of chondrosarcoma of bone and implications for targeted treatment. Lancet Oncol 2005; 6: 599-607.
20. Benoist-Lasselin C, de Margerie E, Gibbs L, et al: Defective chondrocyte proliferation and differentiation in osteochondromas of MHE patients. Bone 2006; 39: 17-26.
21. Hecht JT, Hall CR, Snuggs M, et al: Heparan sulfate abnormalities in exostosis growth plates. Bone 2002; 31: 199-204.
22. Hameetman L, Szuhai K, Yavas A, et al: The role of EXT1 in nonhereditary osteochondroma: identification of homozygous deletions. J Natl Cancer Inst 2007; 99: 396-406.
23. Hameetman L, David G, Yavas A, et al: Decreased EXT expression and intracellular accumulation of heparan sulphate proteoglycan in osteochondromas and peripheral chondrosarcomas. J Pathol 2007; 211: 399-409.
24. Bovée JV: Multiple osteochondromas. Orphanet J Rare Dis 2008; 3: 3.
25. Kronenberg HM: Developmental regulation of the growth plate. Nature 2003; 423: 332-336.
26. Vortkamp A, Lee K, Lanske B, et al: Regulation of rate of cartilage differentiation by Indian Hedgehog and PTH-related protein. Science 1996; 273: 613-622.
27. Bovée JV, Hogendoorn PC, Wunder JS, et al: Cartilage tumours and bone development: molecular pathology and possible therapeutic targets. Nat Rev Cancer 2010; 10: 481-488.
28. Hameetman L, Rozeman LB, Lombaerts M, et al: Peripheral chondrosarcoma progression is accompanied by decreased Indian Hedgehog signalling. J Pathol 2006; 209: 501-511.
29. Hilton MJ, Gutiérrez L, Martinez DA, et al: EXT1 regulates chondrocyte proliferation and differentiation during endochondral bone development. Bone 2005; 36: 379-386.
30. Huch K, Mordstein V, Stöve J, et al: Expression of collagen type I, II, X and Ki-67 in osteochondroma compared to human growth plate cartilage. Eur J Histochem 2002; 46: 249-258.
31. Song L, Tuan RS: Transdifferentiation potential of human mesenchymal stem cells derived from bone marrow. FASEB J 2004; 18: 980-982.
32. Roach HI, Erenpreisa J, Aigner T: Osteogenic differentiation of hypertrophic chondrocytes involves asymmetric cell divisions and apoptosis. J Cell Biol 1995; 131: 483-494.
33. Porter DE, Simpson AH: The neoplastic pathogenesis of solitary and multiple osteochondromas. J Pathol 1999; 188: 119-125.
34. Murphey MD, Choi JJ, Kransdorf MJ, et al: Imaging of osteochondroma: variants and complications with radiologic-pathologic correlation. Radiographics 2000; 20: 1407-1434.
35. Scarborough MT, Moreau G: Benign cartilage tumors. Orthop Clin North Am 1996; 27: 583-589.
36. Abad V, Meyers JL, Weise M, et al: The role of the resting zone in growth plate chondrogenesis. Endocrinology 2002; 143: 1851-1857.
37. Kang JS, Krauss RS: Muscle stem cells in developmental and regenerative myogenesis. Curr Opin Clin Nutr Metab Care 2010; 13: 243-248.
38. Lu SH, Yang AH, Wei CF, et al: Multi-potent differentiation of human purified musclederived cells: potential for tissue regeneration. BJU Int 2010; 105: 1174-1180.